Zobrazeno 1 - 10
of 293
pro vyhledávání: '"Yasuhiro, Gon"'
Autor:
Hiroaki Kodama, Haruyasu Murakami, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Kazushige Wakuda, Ryo Ko, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Shingo Matsumoto, Koichi Goto, Tetsuo Shimizu, Yasuhiro Gon, Toshiaki Takahashi
Publikováno v:
Thoracic Cancer, Vol 15, Iss 21, Pp 1665-1672 (2024)
Abstract Background The AmoyDx Pan lung cancer PCR panel (AmoyDx PLC panel) has been approved as a companion diagnostic tool for multiple anticancer agents in patients with non‐small cell lung cancer (NSCLC). However, the suitability of cytology sp
Externí odkaz:
https://doaj.org/article/6c1fe2baa59945ae9b7a90da2d5d7001
Autor:
Shoko Kotera, MD, Shuichiro Maruoka, MD, PhD, Yusuke Kurosawa, MD, PhD, Hiroyuki Arai, MD, Shiho Yamada, MD, PhD, Asami Fukuda, MD, PhD, Yutaka Kozu, MD, PhD, Hisato Hiranuma, MD, Reiko Ito, MD, PhD, Fumio Shaku, MD, PhD, Yasuhiro Gon, MD, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 3, Pp 100247- (2024)
Background: Dysfunctional breathing (DB) is a clinical condition characterized by irregular breathing patterns presenting a sensation of dyspnea and a feeling of chest tightness. DB is a known comorbidity of asthma that is difficult to control, leadi
Externí odkaz:
https://doaj.org/article/aa71601062be4a8d88eea29660631de7
Autor:
Yuko Iida, Kazushige Wakuda, Hirotsugu Kenmotsu, Kosei Doshita, Hiroaki Kodama, Naoya Nishioka, Eriko Miyawaki, Taichi Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Ryo Ko, Akira Ono, Tateaki Naito, Haruyasu Murakami, Takashi Sugino, Yasuhiro Gon, Toshiaki Takahashi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma (LCNEC) is unclear. This study aimed to evaluate the efficacy of second-line chemotherapy in patients with pulmonary LCNEC. We retrospect
Externí odkaz:
https://doaj.org/article/9ca57d0b679e413492866893556df8e6
Autor:
Yuko Iida, Kazushige Wakuda, Takuya Kawata, Meiko Morita, Motoki Sekikawa, Kosei Doshita, Michitoshi Yabe, Hiroaki Kodama, Keita Miura, Noboru Morikawa, Nobuaki Mamesaya, Haruki Kobayashi, Ryo Ko, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Yasuhiro Gon, Toshiaki Takahashi
Publikováno v:
Thoracic Cancer, Vol 15, Iss 6, Pp 477-485 (2024)
Abstract Background Which patients benefit from the addition of immune checkpoint inhibitors (ICIs) to chemotherapy for small cell lung cancer (SCLC) remains unclear. There have been few reports on the efficacy of ICIs based on conventional immunohis
Externí odkaz:
https://doaj.org/article/e463e71dc180423c8cb17938224f6040
Autor:
Takashi Oki, Yutaka Kozu, Mamiko Hoshi, Yasunori Itoda, Naho Furusho, Ryosuke Ozoe, Yusuke Jinno, Akifumi Hirata, Yusuke Kurosawa, Shiho Yamada, Asami Fukuda, Mari Hikichi, Sotaro Shikano, Kenichi Sugaya, Hisato Hiranuma, Shuichiro Maruoka, Yasuhiro Gon
Publikováno v:
Sleep Science, Vol 17, Iss 02, Pp e143-e150 (2024)
Objective Leptin is an appetite-suppressing hormone released by adipose tissue that plays an important role in severe obstructive sleep apnea syndrome (OSAS). However, it is unclear whether leptin levels are a useful biomarker for this syndrome. The
Externí odkaz:
https://doaj.org/article/75af7ff4b2da4559933c04a2e7ea8362
Autor:
Yuta Ohishi, Yoko Nakanishi, Yukari Hirotani, Atsuko Suzuki, Tomoyuki Tanino, Haruna Nishimaki‐Watanabe, Hiroko Kobayashi, Fumi Nozaki, Sumie Ohni, Xiaoyan Tang, Kentaro Hayashi, Yoshiko Nakagawa, Tetsuo Shimizu, Ichiro Tsujino, Noriaki Takahashi, Yasuhiro Gon, Shinobu Masuda
Publikováno v:
Thoracic Cancer, Vol 15, Iss 1, Pp 89-93 (2024)
Abstract The possibility of stratifying patients according to differences in ROS proto‐oncogene 1 (ROS1) fusion partners has been discussed. This study aimed to clarify the clinicopathological differences between two SDC4::ROS1 positive NSCLC cases
Externí odkaz:
https://doaj.org/article/0ee9eb7bb8d14098bd27a403b28e393c
Autor:
Ippei Miyamoto, Tetsuo Shimizu, Ryo Kusahana, Masayuki Nomoto, Daishi Fujiwara, Tsukasa Nishizawa, Kentaro Hayashi, Yoshiko Nakagawa, Yasuhiro Gon
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Background Anti-aminoacyl-tRNA synthetase (ARS) antibody-positive patients present with a variety of symptoms, including interstitial lung disease (ILD), which is termed anti-synthetase syndrome (ASS). But it is rare that ASS-ILD is consider
Externí odkaz:
https://doaj.org/article/5f052b2e22454d16b1267af52ce95cb2
Autor:
Nobuaki Mamesaya, Hiroaki Kodama, Yuko Iida, Haruki Kobayashi, Ryo Ko, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Tetsuo Shimizu, Yasuhiro Gon, Toshiaki Takahashi
Publikováno v:
Thoracic Cancer, Vol 14, Iss 9, Pp 805-814 (2023)
Abstract Carboplatin plus etoposide is a standard treatment for older extensive‐stage small‐cell lung cancer (ES‐SCLC) patients with performance status (PS) 2. However, older patients often exhibit poor PS (3, 4), and the treatment effect in th
Externí odkaz:
https://doaj.org/article/734358fe8024448d9b3af96c47a4f54d
Publikováno v:
Allergology International, Vol 72, Iss 3, Pp 477-479 (2023)
Externí odkaz:
https://doaj.org/article/fc03784691fd47cabf3f5cd36185021a
Autor:
Yuko Iida, Yoko Nakanishi, Tetsuo Shimizu, Masayuki Nomoto, Yoshiko Nakagawa, Reiko Ito, Noriaki Takahashi, Shinobu Masuda, Yasuhiro Gon
Publikováno v:
Thoracic Cancer, Vol 13, Iss 16, Pp 2362-2370 (2022)
Abstract Background Combined small‐cell lung cancer (cSCLC) is a rare type of small‐cell lung cancer (SCLC) that includes both SCLC and non‐small‐cell lung cancer (NSCLC). The molecular biological mechanisms underlying the heterogeneity of hi
Externí odkaz:
https://doaj.org/article/cc1a90e324c944e5a04fd8827a8327fa